Persistent symptoms of severe and critical COVID-19: A cross-sectional study after more than 120 days from disease onset

Q3 Health Professions Journal of Nature and Science of Medicine Pub Date : 2023-04-01 DOI:10.4103/jnsm.jnsm_139_21
M. Alraddadi, Hamad S. Alyami, N. Alqahtani, N. Khalil, Asmaa Alraddadi, N. Alotaibi
{"title":"Persistent symptoms of severe and critical COVID-19: A cross-sectional study after more than 120 days from disease onset","authors":"M. Alraddadi, Hamad S. Alyami, N. Alqahtani, N. Khalil, Asmaa Alraddadi, N. Alotaibi","doi":"10.4103/jnsm.jnsm_139_21","DOIUrl":null,"url":null,"abstract":"Objective: The objective of this study is to assess the prevalence and predictors of symptom persistence associated with severe and critical coronavirus disease-2019 (COVID-19) after more than 120 days from the onset of the disease. Materials and Methods: This is a single-center, cross-sectional study of 125 adults who were admitted to King Khalid University Hospital (Riyadh, Saudi Arabia) with severe and critical COVID-19 between March 4 and December 1, 2020. Telephone interviews were conducted between April 1 and May 31, 2021, to collect data on COVID-19 symptoms persisting after more than 120 days from the onset of the disease. All of the participants had been discharged from the hospital and had resumed their normal lives. Symptoms of COVID-19 that had not been present before the onset of the disease were considered to be persistent if participants confirmed their continued presence at the time of the interview. The impact of chronic disease on persistent symptoms was considered. Results: About 42.4% (53/125) of patients had at least one or more persistent symptoms; 27.2% (34/125) had breathlessness, 5.6% (7/125) cough, and 4.8% (6/125) chest pain. These three symptoms had been present from the first presentation. Hair loss was reported by 14.4% (18/125), forgetfulness by 8% (10/125), difficulty in concentrating by 6.4% (8/125), and lack of energy by 4% (5/125). Those had manifested after more than 120 days from the symptom's onset. The major factors in suffering from persistent symptoms were intensive care unit (ICU) admission or/and fever (temperature >38°), or/and diarrhea. There was no correlation between persistent symptoms and chronic diseases. Conclusions: After more than 120 days from the confirmation of severe and critical COVID-19, more than one-third of discharged adults were found to have one or more persistent symptoms. These were mainly associated with the need for ICU admission, fever (temperature >38°), and diarrhea. More care needs to be given to COVID-19 patients in the presence of these factors and prolonged medical care would appear to be essential.","PeriodicalId":33866,"journal":{"name":"Journal of Nature and Science of Medicine","volume":"6 1","pages":"84 - 88"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nature and Science of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jnsm.jnsm_139_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The objective of this study is to assess the prevalence and predictors of symptom persistence associated with severe and critical coronavirus disease-2019 (COVID-19) after more than 120 days from the onset of the disease. Materials and Methods: This is a single-center, cross-sectional study of 125 adults who were admitted to King Khalid University Hospital (Riyadh, Saudi Arabia) with severe and critical COVID-19 between March 4 and December 1, 2020. Telephone interviews were conducted between April 1 and May 31, 2021, to collect data on COVID-19 symptoms persisting after more than 120 days from the onset of the disease. All of the participants had been discharged from the hospital and had resumed their normal lives. Symptoms of COVID-19 that had not been present before the onset of the disease were considered to be persistent if participants confirmed their continued presence at the time of the interview. The impact of chronic disease on persistent symptoms was considered. Results: About 42.4% (53/125) of patients had at least one or more persistent symptoms; 27.2% (34/125) had breathlessness, 5.6% (7/125) cough, and 4.8% (6/125) chest pain. These three symptoms had been present from the first presentation. Hair loss was reported by 14.4% (18/125), forgetfulness by 8% (10/125), difficulty in concentrating by 6.4% (8/125), and lack of energy by 4% (5/125). Those had manifested after more than 120 days from the symptom's onset. The major factors in suffering from persistent symptoms were intensive care unit (ICU) admission or/and fever (temperature >38°), or/and diarrhea. There was no correlation between persistent symptoms and chronic diseases. Conclusions: After more than 120 days from the confirmation of severe and critical COVID-19, more than one-third of discharged adults were found to have one or more persistent symptoms. These were mainly associated with the need for ICU admission, fever (temperature >38°), and diarrhea. More care needs to be given to COVID-19 patients in the presence of these factors and prolonged medical care would appear to be essential.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
重症和危重症新冠肺炎的持续症状:发病120天后的横断面研究
目的:本研究的目的是评估重症和危重冠状病毒疾病2019(新冠肺炎)发病120天后症状持续性的患病率和预测因素。材料和方法:这是一项单中心、横断面研究,涉及2020年3月4日至12月1日期间因重症和危重症新冠肺炎入住沙特利雅得哈立德国王大学医院的125名成年人。2021年4月1日至5月31日期间进行了电话采访,以收集新冠肺炎发病120多天后持续症状的数据。所有参与者都已出院,恢复了正常生活。如果参与者在访谈时确认其持续存在,则在疾病发作前未出现的新冠肺炎症状被视为持续存在。考虑了慢性病对持续症状的影响。结果:约42.4%(53/125)的患者至少有一种或多种持续症状;27.2%(34/125)有呼吸困难,5.6%(7/125)有咳嗽,4.8%(6/125)有胸痛。这三种症状从第一次出现时就已经出现了。脱发14.4%(18/125),健忘8%(10/125),难以集中注意力6.4%(8/125),缺乏能量4%(5/125)。这些症状在症状出现120天后出现。持续症状的主要因素是重症监护室(ICU)入院或/和发烧(温度>38°)或/和腹泻。持续症状与慢性病之间没有相关性。结论:在确诊重症和危重症新冠肺炎后120多天,超过三分之一的出院成年人被发现有一种或多种持续症状。这些主要与需要入住ICU、发烧(体温>38°)和腹泻有关。在存在这些因素的情况下,需要为新冠肺炎患者提供更多的护理,延长医疗护理似乎至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Nature and Science of Medicine
Journal of Nature and Science of Medicine Health Professions-Health Professions (miscellaneous)
CiteScore
1.10
自引率
0.00%
发文量
0
审稿时长
31 weeks
期刊最新文献
Menstrual Cycle Changes after the COVID-19 Vaccine: A Cross-sectional Study in Saudi Arabia The Use of Gemcitabine and Docetaxel as a Novel Combination for Hyperthermic Intraperitoneal Chemotherapy in the Management of Recurrent Complicated Abdominal Sarcoma: Case Report and Review of Literature Faculty Experiences: Virtual versus Traditional Problem-based Learning during COVID-19 in a Saudi Medical College CD4+ Tumor-infiltrating Lymphocytes in Neoadjuvant Chemotherapy-treated Invasive Breast Cancer of No Special Type Evaluating the Novel Use of Unmanned Video Objective Structured Clinical Examination Stations in Pediatric Resident Training: Results and Insights
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1